Literature DB >> 27349249

Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma.

Jureeporn Chuerduangphui1,2, Chamsai Pientong1,2, Ponlatham Chaiyarit3,4, Natcha Patarapadungkit5,2, Apinya Chotiyano6,2, Bunkerd Kongyingyoes7, Supannee Promthet8,2, Piyawut Swangphon1,2, Weerayut Wongjampa1,2, Tipaya Ekalaksananan9,10.   

Abstract

Human papillomavirus (HPV) infection modulates several host cytokines contributing to cancer development. Oncostatin M (OSM), an IL-6 family cytokine, acts to promote cell senescence and inhibit growth. Its dysregulation promotes cell survival, cell proliferation and metastasis in various malignancies. The effect of HPV on OSM dysregulation has not been investigated. To elucidate this, immunohistochemistry was used on formalin-fixed, paraffin-embedded oral squamous cell carcinoma (OSCC) tissues: HPV-positive (50) and HPV-negative (50) cases. Immortalized human cervical keratinocytes expressing HPV16E6 (HCK1T, Tet-On system) were used to demonstrate the role of HPV16E6 in OSM expression. In addition, a vector containing HPV16E6/E7 was transiently transfected into oral cancer cell lines. Cell viability, cell-cycle progression and cell migration were evaluated using flow cytometry and a wound healing assay, respectively. The results showed various intensities of OSM expression in OSCC. Interestingly, the median percentages of strongly stained cells were significantly higher in HPV-positive OSCCs than in HPV-negative OSCCs. To explore the role of HPV oncoproteins on OSM expression, the expression of HPV16E6 in the HCK1T Tet-On condition was induced by doxycycline and HPV16E6 was found to significantly upregulate levels of OSM mRNA and protein, with concomitant upregulation of c-Myc. In addition, the levels of OSM mRNA and protein in E6/E7 transiently transfected oral cancer cells also gradually increased in a time-dependent manner and these transfected cells showed greater viability and higher migration rates and cell-cycle progression than controls. This result demonstrates that HPV16 oncoproteins upregulate OSM and play an important role to promote OSCC development.

Entities:  

Keywords:  Human papillomavirus; Interleukin-6; Oncostatin M; Oral squamous cell carcinoma; STAT3; c-Myc

Mesh:

Substances:

Year:  2016        PMID: 27349249     DOI: 10.1007/s12032-016-0800-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.

Authors:  M Mercader; B Taddeo; J R Panella; B Chandran; B J Nickoloff; K E Foreman
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.

Authors:  Chunxia Ren; Xi Cheng; Bei Lu; Gong Yang
Journal:  Eur J Cancer       Date:  2013-08-15       Impact factor: 9.162

3.  Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner.

Authors:  Michael A James; John H Lee; Aloysius J Klingelhutz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma.

Authors:  Benyue Zhang; Ping Li; Exing Wang; Zacharie Brahmi; Kenneth W Dunn; Janice S Blum; Ann Roman
Journal:  Virology       Date:  2003-05-25       Impact factor: 3.616

5.  Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts.

Authors:  Amelia K Scaffidi; Steven E Mutsaers; Yuben P Moodley; Robin J McAnulty; Geoffrey J Laurent; Philip J Thompson; Darryl A Knight
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

6.  OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).

Authors:  Ignacio García-Tuñón; Monica Ricote; Antonio Ruiz; Benito Fraile; Ricardo Paniagua; Mar Royuela
Journal:  Cancer Invest       Date:  2008 Apr-May       Impact factor: 2.176

Review 7.  High-risk human papillomavirus targets crossroads in immune signaling.

Authors:  Bart Tummers; Sjoerd H Van Der Burg
Journal:  Viruses       Date:  2015-05-21       Impact factor: 5.048

8.  HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression.

Authors:  Damian J Junk; Benjamin L Bryson; Mark W Jackson
Journal:  Cancers (Basel)       Date:  2014-03-26       Impact factor: 6.639

9.  Adiponectin Induces Oncostatin M Expression in Osteoblasts through the PI3K/Akt Signaling Pathway.

Authors:  Chen-Ming Su; Wei-Lin Lee; Chin-Jung Hsu; Ting-Ting Lu; Li-Hong Wang; Guo-Hong Xu; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2015-12-25       Impact factor: 5.923

Review 10.  Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.

Authors:  Alfredo Amador-Molina; José Fernando Hernández-Valencia; Edmundo Lamoyi; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2013-10-28       Impact factor: 5.048

View more
  7 in total

1.  HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation.

Authors:  Hong Lou; Joseph F Boland; Hongchuan Li; Robert Burk; Meredith Yeager; Stephen K Anderson; Nicolas Wentzensen; Mark Schiffman; Lisa Mirabello; Michael Dean
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

2.  Helicobacter pylori outer membrane vesicles induce expression and secretion of oncostatin M in AGS gastric cancer cells.

Authors:  Malak Zoaiter; Roudaina Nasser; Rouba Hage-Sleiman; Fadi Abdel-Sater; Bassam Badran; Zaher Zeaiter
Journal:  Braz J Microbiol       Date:  2021-04-13       Impact factor: 2.476

3.  Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  PLoS Pathog       Date:  2019-06-21       Impact factor: 6.823

Review 4.  Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.

Authors:  Nikita Aggarwal; Joni Yadav; Kulbhushan Thakur; Rakhi Bibban; Arun Chhokar; Tanya Tripathi; Anjali Bhat; Tejveer Singh; Mohit Jadli; Ujala Singh; Manoj K Kashyap; Alok C Bharti
Journal:  Front Cell Infect Microbiol       Date:  2020-12-02       Impact factor: 5.293

5.  Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.

Authors:  Jureeporn Chuerduangphui; Tipaya Ekalaksananan; Chukkris Heawchaiyaphum; Patravoot Vatanasapt; Chamsai Pientong
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

Review 6.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.

Authors:  Mingjing Jiang; Bo Li
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

Review 7.  Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  Viruses       Date:  2020-09-03       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.